The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)

Organizer: Yuma Yamada (Fac. Pharm. Sci., Hokkaido Univ.), Sakurai Fuminori (Grad. Sch. Pharm. Sci., Osaka Univ.)

Technology that enables genome regulation by introducing specific genes into target tissues and cells could contribute to the elucidation of various life phenomena, innovative disease treatments and the development of innovative industries. Gene vectors are essential for establishing this technology. This symposium will cover topics in research and development on viral vectors and non-viral vectors such as Lipid Nano Particles and Liposomes as representative gene vectors. Examples of genome regulation implementation will be discussed, including gene replacement therapy via gene transfer, genetic recombination methods and gene genome editing. There will also be a discussion on the regulation related to the development of medicines needed to realize gene-vector-based disease therapies. This symposium will bring together up-and-coming researchers from different research fields specializing in pharmaceutics, virology, molecular biology and regulation for active discussions related to these topics. It is hoped that this symposium will support to realize gene-vector-mediated disease therapy.